Efficacy News and Research

RSS

Delays and lack of communication to primary care physicians common after hospital discharge

Primary care physicians often do not receive adequate patient information from the hospital-based physician following discharge, according to a review article in the February 28 issue of JAMA: The Journal of the American Medical Association.

28 Feb 2007

MatTek's EpiVaginal successfully used in microbicide/HIV study

MatTek Corp. today announced that its patented EpiVaginal human cell-derived tissue model was successfully used in pre-clinical research investigating HIV infection and microbicide interaction.

27 Feb 2007

Drug industry influences breast cancer research

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

27 Feb 2007

FDA approves antidepressant Cymbalta (duloxetine HCl) for treatment of generalized anxiety disorder

Eli Lilly and Company announced today that the U.S. Food and Drug Administration (FDA) has approved the antidepressant Cymbalta (duloxetine HCl) for the treatment of generalized anxiety disorder (GAD), a condition that affects more than 6.5 million American adults in a given year.

26 Feb 2007

Stimuvax investigational lung cancer vaccine phase III study starts

Merck KGaA today announced that the first patient has been enrolled in its global Phase III clinical study, START (Stimulating Targeted Antigenic Responses To NSCLC), assessing the efficacy and safety of Stimuvax (BLP25 liposome vaccine) as a potential treatment for patients with unresectable stage III non-small cell lung cancer (NSCLC).

26 Feb 2007

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

26 Feb 2007

Federal agencies sued over medical Marijuana statements

The Oakland, Calif.-based advocacy group Americans for Safe Access on Wednesday filed suit in Oakland federal court against HHS and FDA over statements the organizations have made about medical marijuana, citing several studies that found the drug might benefit HIV-positive people, the Los Angeles Times reports.

25 Feb 2007

Medical marijuana advocates take HHS to court

Using the latest research to support their claims, advocates for the medical use of marijuana are heading to court.

25 Feb 2007

Call for herpes simplex virus control measures for prevention of HIV transmission

Experts call for HSV control measures, including vaccine, to rank high on international HIV prevention and research agenda as exciting trial findings are published.

22 Feb 2007

New understanding of how and why Taxol works in patients with breast cancer

Cancer researchers at Georgetown University Medical Center have taken a step towards understanding how and why a widely used chemotherapy drug works in patients with breast cancer.

22 Feb 2007

Avastin slows growth of gliomas

Avastin, a relatively new type of drug that shrinks cancerous tumors by cutting off their blood supply, can slow the growth of the most common and deadly form of brain cancer, a pilot study conducted at Duke University Medical Center has found.

20 Feb 2007

Search for vaccine to prevent Chlamydia

It's the most common bacteria-related sexually transmitted disease in the United States, so researchers at The University of Texas at San Antonio's South Texas Center for Emerging Infectious Diseases (STCEID) and The University of Texas at San Antonio Health Science Center have partnered to discover a vaccine that will prevent Chlamydia.

19 Feb 2007

Stroke in young Fabry patients study

Stroke is the second leading cause of mortality worldwide and the most common cause of dementia in western countries.

15 Feb 2007

Sharper MRI's

Magnetic resonance imaging, or MRI, has revolutionized health care, providing doctors with a highly accurate, non-invasive tool for diagnosing cancer, injuries and other maladies within the human body. Now, a Florida State University researcher has collaborated in a research project that could lead to ways of producing even sharper medical images.

13 Feb 2007

Maraviroc to receive accelerated review in U.S. and Europe

Pfizer announced today that marketing authorization applications for maraviroc will receive accelerated review in both the United States and Europe. Accelerated reviews are granted to potential medicines that, if approved, would represent significant improvements over current therapies.

13 Feb 2007

Wealthy nations launch vaccine purchase plan for diseases such as HIV/AIDS, TB, Malaria

Officials from a group of wealthy nations on Friday launched a $1.5 billion plan to provide and develop vaccines for diseases -- including HIV/AIDS, tuberculosis and malaria -- that largely affect developing countries, the New York Times reports.

13 Feb 2007

South Africa starts major HIV/AIDS vaccine trial

The launch of the first large-scale study to evaluate a candidate HIV vaccine on the African continent was announced today by study collaborators in the United States and South Africa. The trial will involve up to 3,000 participants at five sites throughout South Africa and is expected to continue for four years.

11 Feb 2007

High-dose Lipitor therapy cuts risk of hospitalizations for heart failure

Patients with coronary heart disease who took Lipitor (atorvastatin calcium) 80 mg tablets reduced their risk of hospitalizations due to heart failure compared to patients taking the 10 mg dose of Lipitor, according to a new analysis of a subset of patients from the five-year TNT (Treating to New Targets) study, published in today's issue of Circulation.

7 Feb 2007

Natural molecules to create pseudo-cell factories

Carnegie Mellon University's Philip LeDuc predicts the use of artificially created cells could be a potential new therapeutic approach for treating diseases in an ever-changing world.

7 Feb 2007

13 new AIDS vaccine clinical trials initiated in 2006

The International AIDS Vaccine Initiative's (IAVI) January 2007 Annual Issue of VAX, an editorially independent bulletin on AIDS vaccine research published by IAVI, reports that 13 new preventive AIDS vaccine trials were initiated in eight countries around the world in 2006.

6 Feb 2007